# Sprix for Postoperative Pain Control Following Gynecologic Surgery

> **NCT04444830** · PHASE4 · WITHDRAWN · sponsor: **University of Louisville**

## Conditions studied

- Post Operative Pain Control
- Narcotic Use
- Pelvic Organ Prolapse
- Urinary Incontinence , Stress
- Surgery

## Interventions

- **DRUG:** Sprix

## Key facts

- **NCT ID:** NCT04444830
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01
- **Primary completion:** 2021-09-21
- **Final completion:** 2021-09-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never opened to enrollment. Study never IRB approved.
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444830, "Sprix for Postoperative Pain Control Following Gynecologic Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04444830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*